Meininghaus; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meininghaus; Mark.The latest application filed is for "substituted n-arylethyl-2-aminoquinoline-4-carboxamides and use thereof".

Company Profile

7.12.15

Meininghaus; Mark - Wuppertal DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof Grant 11,149,018 - Beck , et al. October 19, 2	2021-10-19
Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof Grant 11,136,296 - Beck , et al. October 5, 2	2021-10-05
Substituted N-arylethyl-2-aminoquinoline-4-carboxamides And Use Thereof App 20200157073 - BECK; Hartmut ; et al.	2020-05-21
Substituted N-arylethyl-2-arylquinoline-4-carboxamides And Use Thereof App 20200031775 - BECK; Hartmut ; et al.	2020-01-30
Positive Allosteric Modulators Of Muscarinic M2 Receptor App 20190367516 - TELLER; Henrik ; et al.	2019-12-05
Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents Grant 10,479,765 - Beck , et al. Nov	2019-11-19
Positive allosteric modulators of muscarinic M2 receptor Grant 10,435,403 - Teller , et al. O	2019-10-08
Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents Grant 10,189,788 - Beck , et al. Ja	2019-01-29
Substituted N,2-diarylquinoline-4-carboxamides And The Use Thereof As Anti-inflammatory Agents App 20190002409 - BECK; Hartmut ; et al.	2019-01-03
Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof Grant 10,117,864 - Beck , et al. November 6, 2	2018-11-06
Positive Allosteric Modulators Of Muscarinic M2 Receptor App 20180297994 - TELLER; Henrik ; et al.	2018-10-18
Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides And Use Thereof App 20180036300 - BECK; Hartmut ; et al.	2018-02-08
Substituted N,2-diarylquinoline-4-carboxamides And The Use Thereof As Anti-inflammatory Agents App 20170260140 - BECK; Hartmut ; et al.	2017-09-14
Substituted piperidines App 20150183773 - JESKE; Mario ; et al.	2015-07-02
Substituted piperidines as Par-1 antagonists Grant 8,987,248 - Jeske , et al. March 24, 2	2015-03-24
Cyclically substituted furopyrimidine derivatives and use thereof Grant 8,324,222 - Lampe , et al. December 4, 2	2012-12-04
Heteroaryl-substituted Piperidines App 20120214788 - Heimbach; Dirk ; et al.	2012-08-23
Substituted 3-(1,2,4-Oxadiazol-5-yl)-5-Phenylpiperidines App 20120129831 - Heimbach; Dirk ; et al.	2012-05-24
Acyclically substituted furopyrimidine derivatives and use thereof Grant 8,183,246 - Lampe , et al. May 22, 2	2012-05-22
Substituted piperidines as Par-1 Antagonists App 20120046268 - Jeske; Mario ; et al.	2012-02-23
Heteroaryl-substituted piperidines Grant 8,119,663 - Heimbach , et al. February 21, 2	2012-02-21
Novel, Cyclically Substituted Furopyrimidine Derivatives and Use Thereof App 20110124665 - Lampe; Thomas ; et al.	2011-05-26
Substituted [(phenylethanoyl)amino]benzamides Grant 7,776,922 - Bruggemeier , et al. August 17, 2	2010-08-17
Novel, Acyclically Substituted Furopyrimidine Derivatives and Use Thereof App 20090318475 - Lampe; Thomas ; et al.	2009-12-24
Heteroaryl-substituted Piperidines App 20090306139 - Heimbach; Dirk ; et al.	2009-12-10
Substituted [(Phenylethanoyl)Amino]Benzamides App 20080171786 - Bruggemeier; Ulf ; et al.	2008-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.